imSAVAR Stakeholder Survey: Views on Adverse Outcome Pathways & Model Grading Systems
The imSAVAR consortium selected four modes of action (MoAs)—CAR Ts, CPIs, BiTEs and IL-2 TREGs—needing …
Blog / Latest News
First paper on “Immunocompetent cancer-on-chip models” published!
The advances in cancer immunotherapy come with several roadblocks limiting their widespread use and their …
3rd imSAVAR Stakeholder Workshop
The third and last of the series of planned imSAVAR Stakeholder Workshops took place over …
2nd imSAVAR Stakeholder Workshop
The imSAVAR second stakeholder workshop was held on the fourth of November 2020. There were …
First imSAVAR Stakeholder Workshop
One of the objectives of imSAVAR is to build a stakeholder community and also get …